4//SEC Filing
Blake John T 4
Accession 0001209191-18-008618
CIK 0001339970other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 8:43 PM ET
Size
11.5 KB
Accession
0001209191-18-008618
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Blake John T
Vice President, Finance
Transactions
- Sale
Common Stock
2018-02-08$3.40/sh−1,402$4,767→ 1,932 total - Exercise/Conversion
Restricted Stock Units
2018-02-07−3,334→ 6,666 totalExercise: $0.00→ Common Stock (3,334 underlying) - Award
Employee Stock Option (right to buy)
2018-02-06+75,000→ 75,000 totalExercise: $3.30Exp: 2028-02-06→ Common Stock (75,000 underlying) - Exercise/Conversion
Common Stock
2018-02-07+3,334→ 3,334 total
Footnotes (4)
- [F1]Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 7, 2017.
- [F2]Sale made by the Reporting Person in compliance with the provisions of Rule 10b5-1 to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 7, 2017.
- [F3]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 6, 2018, such that this option will be fully exercisable on February 6, 2022. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.
- [F4]The RSU grant vests as to one-third (1/3) of the total number of units on each one year anniversary of the grant commencing on February 7, 2018.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001657162
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 8:43 PM ET
- Size
- 11.5 KB